The stock of KUROS BIOSCIENCE LTD. COMMON SHARES (OTCMKTS:CSBTF) registered an increase of 300% in short interest. CSBTF’s total short interest was 400 shares in December as published by FINRA. Its up 300% from 100 shares, reported previously.

It closed at $2.88 lastly. It is down 0.00% since December 7, 2017 and is . It has underperformed by 15.62% the S&P500.

Kuros Biosciences AG, a biopharmaceutical company, engages in the discovery, development, and commercialization of biopharmaceutical products for the treatment and prevention of chronic diseases in the United States, the Kingdom of Saudi Arabia, and internationally. The company has market cap of $26.53 million. The Company’s sealants pipeline products include Neuroseal EU and US for the treatment of dural sealant cranial. It currently has negative earnings. The company's synthetic orthobiologics pipeline products comprise MagnetOs Granules EU and MagnetOs Putty EU for the treatment of orthopedics, spinal, and dental problems; and MagnetOs Granules US and MagnetOs Putty US for the treatment of spinal fusion.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.